APO Research
Talk to an analyst

APO RESEARCH · REPORT

Favipiravir

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Favipiravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025186 pages

Choose your research edition.

Industry ResearchFavipiravir Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Favipiravir Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Favipiravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Favipiravir Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Favipiravir Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Favipiravir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Favipiravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Favipiravir include ChemRar Group, Cipla, Dr. Reddy, Fujifilm, Glenmark, Lupin, R-Pharma, Sun Pharma and Hisun Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Favipiravir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Favipiravir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Favipiravir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Favipiravir market size, projected growth trends, production technologies, key applications, and end-use industries.

Favipiravir Segment by Company

ChemRar Group

Cipla

Dr. Reddy

Fujifilm

Glenmark

Lupin

R-Pharma

Sun Pharma

Hisun Pharm

Favipiravir Segment by Type

Brand Drug

Generic Drug

Favipiravir Segment by Application

Influenza Viruses

COVID-19

Others

Favipiravir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Favipiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Favipiravir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Favipiravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Favipiravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Favipiravir Industry Trends Table 2. Favipiravir Industry Drivers Table 3. Favipiravir Industry Opportunities and Challenges Table 4. Favipiravir Industry Restraints Table 5. Global Favipiravir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Favipiravir Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Favipiravir Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Favipiravir Sales Market Share by Manufacturers Table 9. Global Favipiravir Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Favipiravir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Favipiravir Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Favipiravir Manufacturers, Product Type & Application Table 13. Global Favipiravir Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Favipiravir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Brand Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Favipiravir Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 19. Global Favipiravir Sales by Type (2021-2026) & (K Pcs) Table 20. Global Favipiravir Sales by Type (2027-2032) & (K Pcs) Table 21. Global Favipiravir Sales Market Share by Type (2021-2026) Table 22. Global Favipiravir Sales Market Share by Type (2027-2032) Table 23. Global Favipiravir Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 24. Global Favipiravir Revenue by Type (2021-2026) & (K Pcs) Table 25. Global Favipiravir Revenue by Type (2027-2032) & (K Pcs) Table 26. Global Favipiravir Revenue Market Share by Type (2021-2026) Table 27. Global Favipiravir Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Influenza Viruses Table 29. Major Manufacturers of COVID-19 Table 30. Major Manufacturers of Others Table 31. Global Favipiravir Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 32. Global Favipiravir Sales by Application (2021-2026) & (K Pcs) Table 33. Global Favipiravir Sales by Application (2027-2032) & (K Pcs) Table 34. Global Favipiravir Sales Market Share by Application (2021-2026) Table 35. Global Favipiravir Sales Market Share by Application (2027-2032) Table 36. Global Favipiravir Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 37. Global Favipiravir Revenue by Application (2021-2026) & (K Pcs) Table 38. Global Favipiravir Revenue by Application (2027-2032) & (K Pcs) Table 39. Global Favipiravir Revenue Market Share by Application (2021-2026) Table 40. Global Favipiravir Revenue Market Share by Application (2027-2032) Table 41. Global Favipiravir Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 42. Global Favipiravir Sales by Region (2021-2026) & (K Pcs) Table 43. Global Favipiravir Sales Market Share by Region (2021-2026) Table 44. Global Favipiravir Sales Forecasted by Region (2027-2032) & (K Pcs) Table 45. Global Favipiravir Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 47. North America Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 48. North America Favipiravir Sales by Country (2027-2032) & (K Pcs) Table 49. Europe Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 50. Europe Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 51. Europe Favipiravir Sales by Country (2027-2032) & (K Pcs) Table 52. Asia Pacific Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 53. Asia Pacific Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 54. Asia Pacific Favipiravir Sales by Country (2027-2032) & (K Pcs) Table 55. South America, Middle East and Africa Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. South America, Middle East and Africa Favipiravir Sales by Country (2021-2026) & (K Pcs) Table 57. South America, Middle East and Africa Favipiravir Sales by Country (2027-2032) & (K Pcs) Table 58. Global Favipiravir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Favipiravir Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Favipiravir Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Favipiravir Revenue Market Share by Region (2021-2026) Table 62. Global Favipiravir Revenue Market Share by Region (2027-2032) Table 63. ChemRar Group Company Information Table 64. ChemRar Group Business Overview Table 65. ChemRar Group Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ChemRar Group Favipiravir Product Portfolio Table 67. ChemRar Group Recent Development Table 68. Cipla Company Information Table 69. Cipla Business Overview Table 70. Cipla Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cipla Favipiravir Product Portfolio Table 72. Cipla Recent Development Table 73. Dr. Reddy Company Information Table 74. Dr. Reddy Business Overview Table 75. Dr. Reddy Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Dr. Reddy Favipiravir Product Portfolio Table 77. Dr. Reddy Recent Development Table 78. Fujifilm Company Information Table 79. Fujifilm Business Overview Table 80. Fujifilm Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fujifilm Favipiravir Product Portfolio Table 82. Fujifilm Recent Development Table 83. Glenmark Company Information Table 84. Glenmark Business Overview Table 85. Glenmark Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Glenmark Favipiravir Product Portfolio Table 87. Glenmark Recent Development Table 88. Lupin Company Information Table 89. Lupin Business Overview Table 90. Lupin Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lupin Favipiravir Product Portfolio Table 92. Lupin Recent Development Table 93. R-Pharma Company Information Table 94. R-Pharma Business Overview Table 95. R-Pharma Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. R-Pharma Favipiravir Product Portfolio Table 97. R-Pharma Recent Development Table 98. Sun Pharma Company Information Table 99. Sun Pharma Business Overview Table 100. Sun Pharma Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Sun Pharma Favipiravir Product Portfolio Table 102. Sun Pharma Recent Development Table 103. Hisun Pharm Company Information Table 104. Hisun Pharm Business Overview Table 105. Hisun Pharm Favipiravir Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hisun Pharm Favipiravir Product Portfolio Table 107. Hisun Pharm Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Favipiravir Distributors List Table 111. Favipiravir Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Favipiravir Product Image Figure 2. Global Favipiravir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Favipiravir Market Size (2021-2032) & (US$ Million) Figure 4. Global Favipiravir Sales (2021-2032) & (K Pcs) Figure 5. Global Favipiravir Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Brand Drug Image Figure 9. Generic Drug Image Figure 10. Global Favipiravir Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 11. Global Favipiravir Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Favipiravir Sales Market Share by Type (2021-2032) Figure 13. Global Favipiravir Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Favipiravir Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Favipiravir Revenue Market Share by Type (2021-2032) Figure 16. Influenza Viruses Image Figure 17. COVID-19 Image Figure 18. Others Image Figure 19. Global Favipiravir Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 20. Global Favipiravir Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Favipiravir Sales Market Share by Application (2021-2032) Figure 22. Global Favipiravir Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 23. Global Favipiravir Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Favipiravir Revenue Market Share by Application (2021-2032) Figure 25. North America Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 26. North America Favipiravir Sales Market Share by Country (2021-2032) Figure 27. U.S. Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. Canada Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 29. Mexico Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Europe Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Europe Favipiravir Sales Market Share by Country (2021-2032) Figure 32. Germany Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. France Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. U.K. Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. Italy Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Netherlands Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Asia Pacific Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Asia Pacific Favipiravir Sales Market Share by Country (2021-2032) Figure 39. China Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Japan Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. South Korea Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Southeast Asia Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. India Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Australia Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. South America, Middle East and Africa Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. South America, Middle East and Africa Favipiravir Sales Market Share by Country (2021-2032) Figure 47. Brazil Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South Africa Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. Saudi Arabia Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Turkey Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Argentina Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. UAE Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Egypt Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. Chile Favipiravir Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Global Favipiravir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Favipiravir Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Favipiravir Revenue (2021-2032) & (US$ Million) Figure 58. North America Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Favipiravir Revenue (2021-2032) & (US$ Million) Figure 60. Europe Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Favipiravir Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Favipiravir Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Favipiravir Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Favipiravir Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Influenza Viruses
  • COVID-19
  • Others
Companies covered
  • ChemRar Group
  • Cipla
  • Dr. Reddy
  • Fujifilm
  • Glenmark
  • Lupin
  • R-Pharma
  • Sun Pharma
  • Hisun Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Favipiravir Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Favipiravir Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Favipiravir Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Favipiravir Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Favipiravir Market Dynamics
  1. 2.1 Favipiravir Industry Trends
  2. 2.2 Favipiravir Industry Drivers
  3. 2.3 Favipiravir Industry Opportunities and Challenges
  4. 2.4 Favipiravir Industry Restraints
3 Favipiravir Market by Manufacturers
  1. 3.1 Global Favipiravir Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Favipiravir Sales by Manufacturers (2021-2026)
  3. 3.3 Global Favipiravir Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Favipiravir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Favipiravir Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Favipiravir Manufacturers, Product Type & Application
  7. 3.7 Global Favipiravir Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Favipiravir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Favipiravir Tier 1, Tier 2, and Tier 3
4 Favipiravir Market by Type
  1. 4.1 Favipiravir Type Introduction
  2. 4.1.1 Brand Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Favipiravir Sales by Type
  5. 4.2.1 Global Favipiravir Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Favipiravir Sales by Type (2021-2032)
  7. 4.2.3 Global Favipiravir Sales Market Share by Type (2021-2032)
  8. 4.3 Global Favipiravir Revenue by Type
  9. 4.3.1 Global Favipiravir Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Favipiravir Revenue by Type (2021-2032)
  11. 4.3.3 Global Favipiravir Revenue Market Share by Type (2021-2032)
5 Favipiravir Market by Application
  1. 5.1 Favipiravir Application Introduction
  2. 5.1.1 Influenza Viruses
  3. 5.1.2 COVID-19
  4. 5.1.3 Others
  5. 5.2 Global Favipiravir Sales by Application
  6. 5.2.1 Global Favipiravir Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Favipiravir Sales by Application (2021-2032)
  8. 5.2.3 Global Favipiravir Sales Market Share by Application (2021-2032)
  9. 5.3 Global Favipiravir Revenue by Application
  10. 5.3.1 Global Favipiravir Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Favipiravir Revenue by Application (2021-2032)
  12. 5.3.3 Global Favipiravir Revenue Market Share by Application (2021-2032)
6 Global Favipiravir Sales by Region
  1. 6.1 Global Favipiravir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Favipiravir Sales by Region (2021-2032)
  3. 6.2.1 Global Favipiravir Sales by Region (2021-2026)
  4. 6.2.2 Global Favipiravir Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Favipiravir Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Favipiravir Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Favipiravir Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Favipiravir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Favipiravir Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Favipiravir Revenue by Region
  1. 7.1 Global Favipiravir Revenue by Region
  2. 7.1.1 Global Favipiravir Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Favipiravir Revenue by Region (2021-2026)
  4. 7.1.3 Global Favipiravir Revenue by Region (2027-2032)
  5. 7.1.4 Global Favipiravir Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Favipiravir Revenue (2021-2032)
  8. 7.2.2 North America Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Favipiravir Revenue (2021-2032)
  11. 7.3.2 Europe Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Favipiravir Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Favipiravir Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Favipiravir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ChemRar Group
  2. 8.1.1 ChemRar Group Company Information
  3. 8.1.2 ChemRar Group Business Overview
  4. 8.1.3 ChemRar Group Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ChemRar Group Favipiravir Product Portfolio
  6. 8.1.5 ChemRar Group Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Favipiravir Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Dr. Reddy
  14. 8.3.1 Dr. Reddy Company Information
  15. 8.3.2 Dr. Reddy Business Overview
  16. 8.3.3 Dr. Reddy Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy Favipiravir Product Portfolio
  18. 8.3.5 Dr. Reddy Recent Developments
  19. 8.4 Fujifilm
  20. 8.4.1 Fujifilm Company Information
  21. 8.4.2 Fujifilm Business Overview
  22. 8.4.3 Fujifilm Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fujifilm Favipiravir Product Portfolio
  24. 8.4.5 Fujifilm Recent Developments
  25. 8.5 Glenmark
  26. 8.5.1 Glenmark Company Information
  27. 8.5.2 Glenmark Business Overview
  28. 8.5.3 Glenmark Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Favipiravir Product Portfolio
  30. 8.5.5 Glenmark Recent Developments
  31. 8.6 Lupin
  32. 8.6.1 Lupin Company Information
  33. 8.6.2 Lupin Business Overview
  34. 8.6.3 Lupin Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lupin Favipiravir Product Portfolio
  36. 8.6.5 Lupin Recent Developments
  37. 8.7 R-Pharma
  38. 8.7.1 R-Pharma Company Information
  39. 8.7.2 R-Pharma Business Overview
  40. 8.7.3 R-Pharma Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 R-Pharma Favipiravir Product Portfolio
  42. 8.7.5 R-Pharma Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Favipiravir Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Hisun Pharm
  50. 8.9.1 Hisun Pharm Company Information
  51. 8.9.2 Hisun Pharm Business Overview
  52. 8.9.3 Hisun Pharm Favipiravir Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hisun Pharm Favipiravir Product Portfolio
  54. 8.9.5 Hisun Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Favipiravir Value Chain Analysis
  2. 9.1.1 Favipiravir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Favipiravir Production Mode & Process
  6. 9.2 Favipiravir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Favipiravir Distributors
  9. 9.2.3 Favipiravir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst